| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Executive Chairman | President & CEO
2 companies
Kim D Blickenstaff is Director at NUVB, with reported holdings spanning 2 companies. Kim D Blickenstaff's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.7M at current prices.
Our model assigns Kim D Blickenstaff a middling insider score of 61/100, based on 15 past trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +32.5%.
Kim D Blickenstaff's largest disclosed position is in TNDM as Director, worth about $2.9M. Net of sales, the TNDM filings show accumulation of 789,564 shares.
Kim D Blickenstaff has 49 Form 4 filings on record from February 2016 to May 2026, across 2 companies: Director at Nuvation Bio (NUVB), 2021–2026; Director at Tandem Diabetes Care (TNDM), 2016–2024.
The 120 reported transactions were 61 open-market sales, 24 option exercises, 17 option or other derivative awards and 11 gifts, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 4 purchases worth about $5.0M and 24 sales worth about $149.3M.
The largest open-market purchase was 1,600,000 shares of TNDM at an average $1.25 on March 23, 2017, about $2.0M.
The largest open-market sale was 283,542 shares of TNDM at an average $105.98 on August 7, 2020, about $30.1M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2024 | TNDM Tandem Diabetes Care Inc | Director | Sell | 40,000 | $31.04 | $1,241,400.00 | -19.5% | +3.2% | -30.8% | |
| Jun 11, 2024 | NUVB Nuvation Bio Inc. | Director | Buy | 172,189 | $2.90 | $500,088.51 | New | +4.2% | -22.8% | |
| May 17, 2022 | TNDM Tandem Diabetes Care Inc | Director | Sale+OE | 10,762 | $92.91 | $999,897.42 | -5.0% | -26.0% | -59.3% | |
| Sep 2, 2021 | TNDM Tandem Diabetes Care Inc | Director | Sell | 28,700 | $113.36 | $3,253,418.00 | -12.4% | +9.9% | -60.6% | |
| Aug 17, 2021 | TNDM Tandem Diabetes Care Inc | Director | Sell | 50,000 | $108.96 | $5,448,150.04 | -19.8% | +23.5% | -52.5% | |
| Aug 13, 2021 | TNDM Tandem Diabetes Care Inc | Director | Sell | 63,990 | $106.83 | $6,835,758.81 | -20.2% | +25.0% | -49.7% | |
| Aug 10, 2021 | TNDM Tandem Diabetes Care Inc | Director | Sell | 3,210 | $107.21 | $344,134.15 | -1.0% | +30.9% | -46.5% | |
| Aug 9, 2021 | TNDM Tandem Diabetes Care Inc | Director | Sell | 82,800 | $107.70 | $8,917,606.92 | -20.6% | +26.0% | -50.0% | |
| Jun 8, 2021 | TNDM Tandem Diabetes Care Inc | Director | Sell | 38,000 | $88.14 | $3,349,280.56 | -8.4% | +45.7% | -25.7% | |
| Mar 16, 2021 | TNDM Tandem Diabetes Care Inc | Director | Sell | 200,000 | $87.27 | $17,453,423.24 | -30.7% | +6.7% | +26.0% |